March 19, 2024

Stocks rallied on Tuesday with all three key indexes finishing the day in the green. All eyes and attention remain focused on the Federal Reserve policy meeting currently in progress. The Dow Jones Industrial Average finished the day up 320 points, or 0.83 per cent. The S&P 500 closed up 0.56 per cent, and the […]

Time for gold miner, Genesis Minerals (ASX:GMD) to put up and show the market that it does have a viable growth plan for the next five years, as it has been promising for quite a while. In fact the company has been talking about it for around a year; it has made a big selling

On Tuesday, the ASX experienced gains following the Reserve Bank’s decision to keep the cash rate steady at 4.35 per cent, in line with expectations. The benchmark S&P/ASX 200 Index showed a 0.4 per cent increase, or 27.4 points, reaching 7703.2, after fluctuating between gains and losses prior to the announcement. The materials and energy

Unlike Australia, which didn’t get a rate rise or cut on Tuesday, the Bank of Japan (BoJ) has given that country what amounts to the first rate rise in 17 years. At its meeting on Tuesday, the central bank raised interest rates for the first time since 2007 and became the world’s last central bank

A day after the placement and substantial shareholding notice showing a 19.9 per cent stake emerged from Fortescue (ASX:FMG), Magmatic Resources (ASX:MAG) has given the market the first indication of where it will use the millions of dollars from the deal. Magmatic told the ASX on Tuesday that it will restart gold and copper exploration

No rate cut from the RBA on Tuesday and no increase as well — the cash rate remains at 4.35 per cent for as long as the central bank thinks it is needed to cool inflation. And that will be quite a while yet, judging by the statement from Governor Michell Bullock post meeting. So,

Cyclopharm (ASX:CYC) announced that its first USA Technegas clinical patients were imaged last week at two preeminent clinical sites located in St Louis, Missouri and Stanford, California. These landmark events follow US FDA approval of Technegas last October and the subsequent rollout of the company’s plan for market penetration in medical facilities across the US –

Kiwi-based sportswear retailer KMD Brands (ASX:KMD) has confirmed the weak guidance issued a month ago for a slump in sales and a big loss for the half year to the end of January. The company had warned of the weak result for the January 31 half year in a trading update issued on February 20.

Australian shares drifted in and out of negative territory in thin trading after a positive open as the market awaits the Reserve Bank’s rates decision at 2.30pm and governor Michele Bullock’s press conference. Consensus is for rates to remain unchanged. In company news Boral’s board has recommended that shareholders reject Seven Group takeover offer. The

Kerry Stokes’ Seven Group Holdings (ASX:SVW), hoping for an easy mop-up bid for the rest of Boral (ASX:BLD), has hit heavy going with the target company telling shareholders on Tuesday to reject the offer. Boral’s independent directors said the independent expert (Grant Samuel) had “concluded that the SGH Offer is not fair or reasonable” and